These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3085274)

  • 21. A sensitive peroxidase staining immunoblotting method for measuring total protein S in human plasma.
    Li X; Hatanaka K; Guo L; Tsushima M; Kitamura Y; Yamamoto A
    Thromb Haemost; 1993 Apr; 69(4):331-4. PubMed ID: 8497844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency.
    Nauseef WM; Root RK; Malech HL
    J Clin Invest; 1983 May; 71(5):1297-307. PubMed ID: 6189859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor.
    de Agostini A; Lijnen HR; Pixley RA; Colman RW; Schapira M
    J Clin Invest; 1984 Jun; 73(6):1542-9. PubMed ID: 6725552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contact system dependent fibrinolytic activity in vivo: observations in healthy subjects and factor XII deficient patients.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    Agents Actions Suppl; 1992; 38 ( Pt 2)():292-8. PubMed ID: 1462834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity.
    Iijima K; Arakawa Y; Sugahara Y; Matsushita M; Moriguchi Y; Shimohiro H; Nakagawa M
    Thromb Haemost; 2011 Mar; 105(3):473-8. PubMed ID: 21264442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.
    Bouma BN; Miles LA; Beretta G; Griffin JH
    Biochemistry; 1980 Mar; 19(6):1151-60. PubMed ID: 6768384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factor XII gene alteration in Hageman trait detected by TaqI restriction enzyme.
    Bernardi F; Marchetti G; Patracchini P; del Senno L; Tripodi M; Fantoni A; Bartolai S; Vannini F; Felloni L; Rossi L
    Blood; 1987 May; 69(5):1421-4. PubMed ID: 2882793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficiency and urinary losses of factor XII in adult nephrotic syndrome.
    Vaziri ND; Ngo JL; Ibsen KH; Mahalwas K; Roy S; Hung EK
    Nephron; 1982; 32(4):342-6. PubMed ID: 6820124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel sensitive assay for functional factor XII based on the generation of kallikrein-C1-inhibitor complexes in factor XII-deficient plasma by glass-bound factor XII.
    Dors DM; Nuijens JH; Huijbregts CC; Hack CE
    Thromb Haemost; 1992 Jun; 67(6):644-8. PubMed ID: 1509403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
    Seligsohn U; Osterud B; Brown SF; Griffin JH; Rapaport SI
    J Clin Invest; 1979 Oct; 64(4):1056-65. PubMed ID: 479368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of a high molecular weight variant of prolactin in human plasma by a combination of electrophoretic and immunologic techniques.
    Sinha YN; Gilligan TA; Lee DW
    J Clin Endocrinol Metab; 1984 Apr; 58(4):752-4. PubMed ID: 6199365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioimmunoassay of human Hageman factor (factor XII).
    Saito H; Ratnoff OD; Pensky J
    J Lab Clin Med; 1976 Sep; 88(3):506-14. PubMed ID: 956701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between kallikrein release and factor XII in normal persons and carriers of the Hageman trait.
    Torres M; Ercoreca L; Lucia JF; Giralt M; Raichs A
    Thromb Haemost; 1979 Dec; 42(4):1286-8. PubMed ID: 261563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.
    Thompson AR
    Thromb Haemost; 1982 Aug; 48(1):27-32. PubMed ID: 6813992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of an association between factor XII and kallikrein in human plasma--significance of storage of plasma and the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1992 May; 66(4):421-34. PubMed ID: 1412207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low levels of plasma protein S, protein C and coagulation factor XII during early pregnancy and adverse pregnancy outcome.
    Ebina Y; Ieko M; Naito S; Kobashi G; Deguchi M; Minakami H; Atsumi T; Yamada H
    Thromb Haemost; 2015 Jul; 114(1):65-9. PubMed ID: 25879167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of an hereditary coagulation factor XII deficiency in a consanguineous pedigree].
    Zhang Y; Xie HX; Wang MS; Jin YH; Xie YS; Zheng FX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):666-9. PubMed ID: 22161101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of bradykinin are suppressed in factor XII-deficient mice.
    Iwaki T; Castellino FJ
    Thromb Haemost; 2006 Jun; 95(6):1003-10. PubMed ID: 16732380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasma factor XII (Hageman factor) in disease states (author's transl)].
    Ichinose A; Maruyama I; Imaguma M; Sonoda T; Igata A
    Rinsho Ketsueki; 1981 Aug; 22(8):1232-6. PubMed ID: 7328776
    [No Abstract]   [Full Text] [Related]  

  • 40. Heterogeneity of human factor V deficiency. Evidence for the existence of antigen-positive variants.
    Chiu HC; Whitaker E; Colman RW
    J Clin Invest; 1983 Aug; 72(2):493-503. PubMed ID: 6348091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.